BREAK THROUGH
Embrace the Challenge With ONO
ONO PHARMA USA is a pharmaceutical company dedicated to developing innovative medicines across oncology, neurology, immunology, and specialty.
Who We Are
ONO PHARMA USA is the United States subsidiary of ONO PHARMACEUTICAL CO., LTD., a pharmaceutical company founded in Osaka, Japan in 1717. Throughout our rich history, our mission has been to develop novel therapeutics to help patients live longer, healthier lives.
Always Innovative. Always ONO.
Embrace the Challenge with ONO PHARMA USA as we challenge boundaries and pursue innovative new treatments.
Rooted in Innovative Research & Development
We believe innovation in the lab can make a meaningful difference in people’s lives. That’s why we focus on areas with high unmet clinical need and partner with leading research and academic institutions – to bring new treatment options to people who need them most.
 Oncology With a history of pioneering in oncology, we are committed to developing innovative treatments for a range of cancers. |  Immunology We’re working toward drug discovery in cancer immunotherapy and autoimmune therapy. |
 Neurology We’re developing treatments that have the potential to treat a range of neurodegenerative diseases. |  Specialty Across therapeutic areas, we’re working to discover medicines to address high unmet need. |
Our Research Pipeline
We have a strong pipeline of investigational therapies in oncology and neurology and are actively expanding our clinical trial program in the United States.
Our World Class Team
Our people are the heart of our work. Every day, team members across the organization collaborate to advance therapeutics with the potential to make a meaningful difference in patients’ lives.
Latest News at ONO PHARMA USA
Our parent company, Ono Pharmaceutical Co. Ltd., has established an independent non-profit foundation – the ONO PHARMA Foundation. The ONO PHARMA Foundation supports academic research in relevant scientific fields with the potential to make significant impact on therapeutic approaches to disease and pain management.
Our Global Pipeline
ONO is investigating additional therapeutics across our four focus areas globally.
